Recent Updates
Recently added Catalysts
ALT

Altimmune Appoints Raymond Jordt as Chief Business Officer

Key Takeaway: Altimmune Appoints Raymond Jordt as Chief Business Officer
Price reaction · baseline $15.63 (2023-01-03 close) · hit after-hours · clean, no other ALT news in the window
day 0 close
-5.2%
day 1
-8.3%
day 3 · peak
-10.6%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+22%
120-day peak, hindsight
Typical move
10.2%
average across 8 past catalysts
Cash runway
~64 mo
Minimal dilution risk
Lead asset
ALT-801
Phase 2 · Obesity/Overweight

Full Press Release Details

Altimmune Appoints Raymond Jordt as Chief Business Officer.
Last updated: Jan 4, 2023